Genentech leases 229K sf Boston Properties-Alexandria project in South SF

Deal highlights demand, limited supply in Bay Area life science real estate market

San Francisco /
Dec.December 07, 2021 09:13 AM
Boston Properties' Bob Pester,  Alexandria Real Estate Equities'  Joel Marcus and a rendering of 751 Gateway Boulevard (Boston Properties, Getty, Facebook)
Boston Properties’ Bob Pester,  Alexandria Real Estate Equities’  Joel Marcus and a rendering of 751 Gateway Boulevard (Boston Properties, Getty, Facebook)

Genentech leased a 229,000-square-foot project in South San Francisco, highlighting the intense demand and limited supply of available property in the Bay Area’s life science real estate market.

The South San Francisco-based biotech firm agreed to rent the entire project at 751 Gateway Boulevard, according to the San Francisco Business Times. The development is about a mile from the firm’s corporate headquarters, which totals about 4.7 million square feet, the Business Times reported.

The project, a joint venture between Boston Properties and Alexandria Real Estate Equities, is under construction and slated for initial occupancy in early 2024, Boston Properties said in a news release. The REIT, which specializes in building, owning, and managing Class A offices, will own 49 percent of the development upon completion, and Alexandria will own the rest.

South San Francisco “continues to be the location of choice for leading life science companies,” Bob Pester, Boston Properties’ executive vice president for the San Francisco region, said in the release. The San Mateo County city, home to more than 200 biotech companies, touts itself as the birthplace of the industry and says it’s the largest biotech cluster in the world.

The Gateway Boulevard development is the first phase of a multi-phase life science project at the site of an existing office and lab campus named Gateway Commons. Boston Properties and Alexandria have the option to develop at least another 411,000 square feet of life science property there across two projects, assuming they get the city’s approval.

Genentech’s decision to lease almost two years before it can move in reflects the industry’s local supply-demand imbalance. Companies are building more than 3 million square feet of lab space in the Bay Area, compared with more than 4.5 million square feet of active tenant requirements, according to third-quarter data from Kidder Mathews.

The vacancy rate for such space, meanwhile, was less than 3 percent at the end of last quarter, relatively flat compared with the previous three months, Kidder Mathews says.

[San Francisco Business Times] — Matthew Niksa





    Related Articles

    arrow_forward_ios
    Boston Properties' Owen D. Thomas and renderings for 725 Harrison Street, San Francisco (BXP, HOK, iStock)
    Developer enlarges plan for tower in SF’s SoMa
    Developer enlarges plan for tower in SF’s SoMa
    Summit Hotel Properties president and ceo Jonathan P. Stanner with the Hilton Garden Inn San Francisco Airport North at 670 Gateway Blvd. in South San Francisco (Google Maps, Summit Hotel Properties)
    SFO-adjacent Hilton Garden Inn trades above pre-pandemic price
    SFO-adjacent Hilton Garden Inn trades above pre-pandemic price
    InterVenn Biosciences' Aldo Carrascoso and rendering of building at 499 Forbes Blvd (Woods Bagot, InterVenn Biosciences, iStock)
    Biotech startup takes entire spec development in South SF
    Biotech startup takes entire spec development in South SF
    Bell Partners president and ceo Lili F. Dunn with renderings of Cadence Apartments at 400 Cypress Avenue in South San Francisco (Chet Frohlich, Bell Partners Inc.)
    Builder sells 260-unit apartment complex in South San Francisco
    Builder sells 260-unit apartment complex in South San Francisco
    SteelWave’s Steve Dunn and 101 Terminal Court (LinkedIn, Google Maps)
    SteelWave pays $85M for South SF parking lot
    SteelWave pays $85M for South SF parking lot
    IQHQ's Tracy Murphy with rendering or 10 Twin Dolphin Drive proposal (IDHQ, RIOS)
    Developer envisions 654K sf for life science on former Oracle site in Redwood City
    Developer envisions 654K sf for life science on former Oracle site in Redwood City
    Presidio Bay’s K. Cyrus Sanandaji with 777 Industrial Road (Presidio Bay Ventures)
    Sanandaji’s Presidio Bay places $118M spec bet with latest life science development on Peninsula
    Sanandaji’s Presidio Bay places $118M spec bet with latest life science development on Peninsula
    CIRM's Maria Millan and 601 Gateway Blvd. (Loopnet, LinkedIn, iStock)
    State stem cell agency to move HQ to South San Francisco
    State stem cell agency to move HQ to South San Francisco
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...